|
Peg Interferon alfa-2b/Ribavirin
Peg Interferon alfa-2b/Ribavirin
| |
Pegylated interferon-alpha2b plus ribavirin: an efficacious and
well-tolerated treatment regimen for patients
with hepatitis C virus related histologically proven cirrhosis.
Roffi L, Colloredo G, Pioltelli P, et al
Antivir Ther. 2008;13(5):663-73.
Abstract
Pegylated alpha-interferon-2a plus ribavirin compared with pegylated
alpha-interferon-2b plus ribavirin for initial
treatment of chronic hepatitis C virus: Prospective, non-randomized study.
Escudero A, Rodríguez F, Serra MA, et al
J Gastroenterol Hepatol. 2008 Apr 19
Abstract
|
Impact of weight-based ribavirin with peginterferon alfa-2b in african
americans with
hepatitis C virus genotype 1.
Jacobson IM, Brown RS Jr, McCone J, et al
Hepatology. 2007 Sep 25;46(4):982-990
Abstract
|
FULL TEXT
ARTICLE
Using pegylated interferon alfa-2b and ribavirin to treat chronic
hepatitis patients infected
with hepatitis c virus genotype 1: are nonresponders and relapsers
different populations?
Silva GF, Polônio RJ, Pardini MI, et al
Braz J Infect Dis. 2007 Dec;11(6):554-60.
Paper
|
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic
hepatitis C patients:
A randomized trial.
Jacobson IM, Brown RS Jr, Freilich B, et al
Hepatology. 2007 Sep 25;46(4):971-981
Abstract
|
Effect of treatment with interferon alpha-2b and ribavirin in
patients infected with genotype 2
hepatitis C virus.
Nagase Y, Yotsuyanagi H, Okuse C, et al
Hepatol Res. 2007 Sep 6;
Abstract
|
Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in
interferon-naïve patients
with chronic hepatitis C: a randomized, controlled study.
Bruno R, Sacchi P, Scagnolari C. et al
Aliment
Pharmacol Ther. 2007 Aug 1;26(3):369-76.
Abstract |
Pegylated interferon and ribavirin combination therapy for
chronic hepatitis C in patients with
congenital
bleeding disorders: a single-centre experience.
Posthouwer D, Fischer K, DE Heusden N, et al
Haemophilia. 2007
Jan;13(1):98-103.
Abstract
|
Pegylated interferon and ribavirin in re-treatment of
responder-relapser HCV patients.
Basso M, Torre F, Grasso A, et al
Dig Liver Dis.
2006 Oct 30;
Abstract
|
Hepatitis C virus survival curve analysis in naive patients treated with
peginterferon alpha-2b
plus ribavirin. A randomized controlled trial for induction with high
doses of peginterferon and
predictability of sustained viral response from early virologic data.
Mimidis K, Papadopoulos VP, Elefsiniotis I, et al
J Gastrointestin Liver Dis. 2006
Sep;15(3):213-9.
Abstract
Sustained Viral Response to Pegylated Interferon alpha-2b and Ribavirin in
Chronic Hepatitis C
Refractory to Prior Treatment.
Mathew A, Peiffer LP, Rhoades K, McGarrity T.
Dig Dis Sci. 2006 Sep 27;
Abstract |
Efficacy and Safety of Pegylated Interferon-alpha2b Plus Ribavirin for the
Treatment of Chronic
Hepatitis C in HIV-Infected Patients.
Santin M, Shaw E, Garcia MJ, et al
AIDS Res Hum Retroviruses. 2006 Apr;22(4):315-20.
Abstract
|
Peginterferon Alfa-2a plus Ribavirin
for Chronic Hepatitis C Virus Infection in HIV-Infected Patients.
Torriani FJ, Rodriguez-Torres M, Rockstroh, et al
N Engl J Med. 2004 Jul
29;351(5):438-450.
Abstract
|
Treatment
of chronic hepatitis C infection with peginterferons plus ribavirin.
Fried MW, Hadziyannis SJ.
Semin Liver Dis. 2004 May;24 Suppl
2:47-54.
Abstract
|
Response to combination therapy of interferon alfa-2b plus ribavirin in
Hispanics with chronic
hepatitis C.
Munoz H, Arroyo J, Torres EA, De Jesus-Monge, et al
P R Health Sci J. 2004 Jun;23(2 Suppl):61-7.
Abstract
|
|
|
|
Peg Interferon alfa -2b
Monotherapy vs
Peg Interferon alfa-2b/Ribavirin
|
Peg Interferon alfa-2b
Monotherapy vs Standard
Interferons
|
Peg Interferon alfa-2b/Ribavirin
|
|
Peg Interferon alfa-2b/Ribavirin
|
Peg Interferon alfa-2b/Ribavirin
|
Peg Interferon alfa-2b/Ribavirin/Merimempodib
|
Peginterferon alfa-2b
HCV Efficacy |
| | |
Acute
HCV
Peg
Inf Alfa-2b Journal Main Page 
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader